Novigenix AI is a TechBio that powers precision medicine through its proprietary AI-enabled liquid biopsy mRNA platform, LITOSeek, to map immune-response dynamics across disease onset and progression—turning biology into actionable insights for therapy development.

Products, services, technology

Our AI-enabled ISO-13485 certified platform delivers ImmunoPD biomarkers, insights into mechanism of action and resistance, and early markers for severe toxicity to accelerate clinical development of ADCs, radioligand therapy, cellular therapies, therapeutic vaccines, and immunotherapies.

Location

Additional address info

  • Biopôle IV

Canton

Facts & figures

  • Type of organization
    Private company
  • Year of foundation
    2025
  • Number of employees in Switzerland
    10-19

Keep browsing

You may also be interested in